The weight-loss jabs juggernaut is showing no signs of slowing down. While the medicines arrived as obesity treatments only four years ago, the number of people in the UK using the injections is expected to reach one million this year. As relatively new drugs, evidence about their effects on the body is still emerging. The … Read more
(MedPage Today) — Another benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ablation, according to a large Veterans Affairs database. New initiators of these drugs in 2015-2022…
by Michael Monostra Fact Checked by Richard Smith from Endocrine Today/Healio NewsPublished April 25, 2025 According to findings from a microsimulation model, covering obesity medications under Medicare Part D is projected to significantly increase federal spending, estimated at $47.7 billion over ten years. While these drugs may reduce healthcare costs associated with obesity-related conditions, these savings are currently not … Read more
There’s never a dull day in the world of weight-loss medication. This week brought new restrictions on compounded GLP-1 medication, the cheaper, copycat versions of brand-name drugs that telehealth companies like Hims & Hers and Noom had been offering. Other developments include news that GLP-1 pills are on the way, and that a bankruptcy filing … Read more